Invention Grant
- Patent Title: Heteroaryltrifluoroborate compounds for the treatment of mycobacterial infections
-
Application No.: US16335326Application Date: 2017-10-05
-
Publication No.: US11261200B2Publication Date: 2022-03-01
- Inventor: Takushi Kaneko , Nader Fotouhi
- Applicant: The Global Alliance for TB Drug Development, Inc.
- Applicant Address: US NY New York
- Assignee: The Global Alliance for TB Drug Development, Inc.
- Current Assignee: The Global Alliance for TB Drug Development, Inc.
- Current Assignee Address: US NY New York
- International Application: PCT/US2017/055230 WO 20171005
- International Announcement: WO2018/067762 WO 20180412
- Main IPC: C07F5/02
- IPC: C07F5/02 ; A61P31/06 ; A61K31/69 ; A61K45/06 ; A61K31/4409 ; A61K31/4965
Abstract:
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of tuberculosis.
Public/Granted literature
- US20190276478A1 HETEROARYLTRIFLUOROBORATE COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS Public/Granted day:2019-09-12
Information query
